Pulmonx Corporation

LUNG · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$56-$61-$59-$49
Dep. & Amort.$1$2$4$3
Deferred Tax$0$0$0-$0
Stock-Based Comp.$23$22$0$0
Change in WC-$2-$3-$7-$8
Other Non-Cash$2$2$17$12
Operating Cash Flow-$32-$38-$45-$41
Investing Activities
PP&E Inv.-$1-$1-$1-$4
Net Acquisitions$0$0$0$0
Inv. Purchases-$28-$46-$47-$53
Inv. Sales/Matur.$47$45$44$10
Other Inv. Act.$0$0$0$0
Investing Cash Flow$17-$2-$4-$46
Financing Activities
Debt Repay.-$0$20-$0$0
Stock Issued$0$0$3$5
Stock Repurch.$0$0-$0-$0
Dividends Paid$0$0$0$0
Other Fin. Act.$1$1$0$0
Financing Cash Flow$1$21$2$4
Forex Effect$0$0$0$0
Net Chg. in Cash-$13-$18-$47-$83
Supplemental Information
Beg. Cash$84$102$149$232
End Cash$71$84$102$149
Free Cash Flow-$33-$38-$46-$45
Pulmonx Corporation (LUNG) Financial Statements & Key Stats | AlphaPilot